Omeros (OMER) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Omeros (OMER) Net Income towards Common Stockholders Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Omeros |
628.56 Mn |
493.24 Mn |
9.31 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-20.00% |
| Dec 31, 2025 |
15.89% |
| Sep 30, 2025 |
24.12% |
| Jun 30, 2025 |
15.03% |
| Mar 31, 2025 |
16.42% |
| Dec 31, 2024 |
15.40% |
| Sep 30, 2024 |
18.09% |
| Jun 30, 2024 |
21.16% |
| Mar 31, 2024 |
17.80% |
| Dec 31, 2023 |
26.81% |
| Sep 30, 2023 |
18.61% |
| Jun 30, 2023 |
17.12% |
| Mar 31, 2023 |
17.04% |
| Dec 31, 2022 |
65.16% |
| Sep 30, 2022 |
46.43% |
| Jun 30, 2022 |
22.33% |
| Mar 31, 2022 |
19.35% |
| Dec 31, 2021 |
90.24% |
| Sep 30, 2021 |
28.64% |
| Jun 30, 2021 |
29.83% |
